Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Marksans Pharma Limited ( (IN:MARKSANS) ) has issued an announcement.
Marksans Pharma Limited has announced an addendum to the notice of its 33rd Annual General Meeting, as published in the Business Standard and Lakshadeep newspapers. This announcement is part of the company’s compliance with regulatory requirements, reflecting its commitment to transparency and effective communication with stakeholders.
More about Marksans Pharma Limited
Marksans Pharma Limited operates in the pharmaceutical industry, focusing on the development, manufacturing, and marketing of a wide range of pharmaceutical products. The company primarily serves the global market with a variety of generic drugs and over-the-counter medications.
Average Trading Volume: 98,784
Technical Sentiment Signal: Buy
Current Market Cap: 103.3B INR
For an in-depth examination of MARKSANS stock, go to TipRanks’ Overview page.